London

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Celgene3 trials

Closed trials

• Completed

  An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

  NCT03952039· Phase 3· Celgene· Source

• Completed

  Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

  NCT03484702· Phase 2· Celgene· Source

• Completed

  An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

  NCT02577406· Phase 3· Celgene· Source